A David Mendelow
Overview
Explore the profile of A David Mendelow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
4422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Gregson B, Metcalfe S, Iqbal A, Rowan E, Prasad M, Bhattathiri P, et al.
Br J Neurosurg
. 2023 May;
37(6):1635-1642.
PMID: 37161757
Background: The surgical trial of lobar intracerebral haemorrhage (STICH II) was a randomised controlled trial evaluating early surgical removal of a clot. This paper investigates volume change in both arms...
4.
Kolias A, Adams H, Timofeev I, Corteen E, Hossain I, Czosnyka M, et al.
JAMA Neurol
. 2022 Jun;
79(7):664-671.
PMID: 35666526
Importance: Trials often assess primary outcomes of traumatic brain injury at 6 months. Longer-term data are needed to assess outcomes for patients receiving surgical vs medical treatment for traumatic intracranial...
5.
Polster S, Carrion-Penagos J, Lyne S, Gregson B, Cao Y, Thompson R, et al.
Neurosurgery
. 2021 Jan;
88(5):961-970.
PMID: 33475732
Background: The extent of intracerebral hemorrhage (ICH) removal conferred survival and functional benefits in the minimally invasive surgery with thrombolysis in intracerebral hemorrhage evacuation (MISTIE) III trial. It is unclear...
6.
Polster S, Carrion-Penagos J, Lyne S, Goldenberg F, Mansour A, Ziai W, et al.
Oper Neurosurg (Hagerstown)
. 2020 Dec;
20(1):98-108.
PMID: 33313847
Background: Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) procedure was recently tested in a large phase III randomized trial showing a significant probability of...
7.
Ziai W, McBee N, Lane K, Lees K, Dawson J, Vespa P, et al.
Int J Stroke
. 2019 Apr;
14(5):548-554.
PMID: 30943878
Rationale And Hypothesis: Surgical removal of spontaneous intracerebral hemorrhage may reduce secondary destruction of brain tissue. However, large surgical trials of craniotomy have not demonstrated definitive improvement in clinical outcomes....
8.
Gregson B, Mitchell P, Mendelow A
Stroke
. 2019 Apr;
50(5):1108-1115.
PMID: 30932784
Background and Purpose- The STICH (Surgical Trial in Lobar Intracerebral Haemorrhage) I and II trials randomized patients with spontaneous intracerebral hemorrhage (ICH) to early surgery or initial conservative treatment. Both...
9.
Awad I, Polster S, Carrion-Penagos J, Thompson R, Cao Y, Stadnik A, et al.
Neurosurgery
. 2019 Mar;
84(6):1157-1168.
PMID: 30891610
Background: Minimally invasive surgery procedures, including stereotactic catheter aspiration and clearance of intracerebral hemorrhage (ICH) with recombinant tissue plasminogen activator hold a promise to improve outcome of supratentorial brain hemorrhage,...
10.
Hanley D, Thompson R, Rosenblum M, Yenokyan G, Lane K, McBee N, et al.
Lancet
. 2019 Feb;
393(10175):1021-1032.
PMID: 30739747
Background: Acute stroke due to supratentorial intracerebral haemorrhage is associated with high morbidity and mortality. Open craniotomy haematoma evacuation has not been found to have any benefit in large randomised...